4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-24-016776
Director bought 2,500 shares at $6.40 ($16,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ASELAGE STEVE Director | 2024-05-24 | Purchase | +2,500 | $6.40 | $16,000 | 2,500 | I: show line 1 in the form |
| Open-market purchases · 2,500 sh · avg $6.40 · $16,000 | |||||||
Loading xslF345X05/form4.xml…